STELLA PHARMA CORPORATION (4888.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−11.1x

Market Cap

JPY 12.18B

MomentumView details →

1D Return

+0.85%

YTD Return

+77.83%

RSI (14)

59.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−11.1x

Market Cap

JPY 12.18B

RSI (14)

59.3

MomentumView details →

1D Return

+0.85%

YTD Return

+77.83%

ProfitabilityView details →

Gross Margin

86.43%

Net Margin

−241.49%

EBITDA Margin

−222.72%

ROE (TTM)

−32.15%

ROA (TTM)

−17.39%

Asset Turnover

0.07x

GrowthView details →

Revenue YoY

−66.39%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+12.15%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.31x

Current Ratio

16.75x

Quick Ratio

12.10x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

323.00M

Net Income (TTM)

−780.00M

Op. CF (TTM)

—

Next earningsNov 5, 2026 →

Latest newsMore news →

Stella Pharma announced a third-party allotment of 1 million shares to CVI Investments at an issue price of 299 yen per share.22d ago

China Bio-Pharmaceutical Services signed a master cooperation agreement with Stella Pharma to jointly develop and commercialize Steboronine, the world's first approved boron neutron capture therapy drug, in China.24d ago

Similar companies

MediciNova,Inc.4875.T TAIKO PHARMACEUTICAL CO.,LTD.4574.T RaQualia Pharma Inc.4579.T AnGes,Inc.4563.T WAKAMOTO PHARMACEUTICAL CO.,LTD.4512.T Renascience Inc.4889.T Find similar companies →

Latest newsMore news →

Stella Pharma announced a third-party allotment of 1 million shares to CVI Investments at an issue price of 299 yen per share.22d ago China Bio-Pharmaceutical Services signed a master cooperation agreement with Stella Pharma to jointly develop and commercialize Steboronine, the world's first approved boron neutron capture therapy drug, in China.24d ago